Edwards Lifesciences Corporation (EW)
NYQ · Medical Devices
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Peers in Medical Devices
All in industry →Abbott Laboratories
Stryker Corporation
Medtronic plc
Boston Scientific Corporation
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
DexCom, Inc.
STERIS plc
Zimmer Biomet Holdings, Inc.
Smith & Nephew plc
Recent press releases
April 2026
EW Raises 2026 Guidance After Strong Q1 Earnings
# 🧾 What This Document Is This is an **earnings release** – a quarterly report card for investors. Edwards Lifesciences is telling the world how much money it made, spent, and earned from January to March 2026. It’s also updating its predictions for the rest of the year. 👉 **Key takeaway:** The co
SEC filings
All filings →Insider trades
All insider trades →Edwards Lifesciences Corporation has no reported insider trades in the last 90 days.